trending Market Intelligence /marketintelligence/en/news-insights/trending/mpLVs_u1x3tC29_p8zqZMg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Sogo Medical fiscal Q4 profit climbs 15.0% YOY

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Sogo Medical fiscal Q4 profit climbs 15.0% YOY

Sogo Medical Co. Ltd. said its normalized net income for the fiscal fourth quarter ended March 31 amounted to ¥97.05 per share, an increase of 15.0% from ¥84.43 per share in the year-earlier period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was ¥1.40 billion, a gain of 15.0% from ¥1.22 billion in the prior-year period.

The normalized profit margin rose to 4.8% from 4.2% in the year-earlier period.

Total revenue totaled ¥28.93 billion, compared with ¥28.83 billion in the year-earlier period, and total operating expenses totaled ¥26.74 billion, compared with ¥26.88 billion in the prior-year period.

Reported net income came to ¥1.12 billion, or ¥77.30 per share, compared to ¥1.11 billion, or ¥76.60 per share, in the prior-year period.

For the year, the company's normalized net income totaled ¥226.92 per share, a gain from ¥219.20 per share in the prior year.

Normalized net income was ¥3.28 billion, an increase from ¥3.16 billion in the prior year.

Full-year total revenue grew year over year to ¥107.94 billion from ¥103.32 billion, and total operating expenses increased year over year to ¥102.93 billion from ¥98.30 billion.

The company said reported net income decreased year over year to ¥2.77 billion, or ¥192.13 per share, in the full year, from ¥2.86 billion, or ¥197.81 per share.

As of June 19, US$1 was equivalent to ¥122.78.